{"entity":{"type":"insider","cik":"0001975404","url":"/insider/0001975404","json_url":"/insider/0001975404.json","name":"Watton Corey Michael","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":6,"n_filings":6,"first":"2023-05-31","last":"2026-08-12","span_basis":"filed_date"},"name_variants":[{"name":"Watton Corey Michael","source":"filing","n_filings":6,"first_seen":"2023-05-31","last_seen":"2026-08-12"}],"transactions":[{"id":9287721,"accession":"0001434647-26-000070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001434647-26-000070","line_url":"/filing/0001434647-26-000070#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001975404","owner_name":"Watton Corey Michael","owner_url":"/insider/0001975404","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12300.0,"shares_display":"12,300","price_per_share":11.2502,"price_display":"11.25","price_state":"stated","total_value":138377.46,"total_display":"138,377.46","shares_owned_after":1800.0,"shares_owned_after_display":"1,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-10","filed_date":"2026-08-12","scope":"insider"},{"id":4359580,"accession":"0001437749-25-010332","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-25-010332","line_url":"/filing/0001437749-25-010332#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001975404","owner_name":"Watton Corey Michael","owner_url":"/insider/0001975404","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":300.0,"shares_display":"300","price_per_share":7.8384,"price_display":"7.84","price_state":"stated","total_value":2351.52,"total_display":"2,351.52","shares_owned_after":1800.0,"shares_owned_after_display":"1,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-03-28","filed_date":"2025-03-31","scope":"insider"},{"id":2398712,"accession":"0001437749-24-031367","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-24-031367","line_url":"/filing/0001437749-24-031367#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001975404","owner_name":"Watton Corey Michael","owner_url":"/insider/0001975404","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":7.9153,"price_display":"7.92","price_state":"stated","total_value":3957.65,"total_display":"3,957.65","shares_owned_after":1500.0,"shares_owned_after_display":"1,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-11","filed_date":"2024-10-16","scope":"insider"},{"id":8036310,"accession":"0001437749-23-018447","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-018447","line_url":"/filing/0001437749-23-018447#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001975404","owner_name":"Watton Corey Michael","owner_url":"/insider/0001975404","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":275.0,"shares_display":"275","price_per_share":5.9479,"price_display":"5.95","price_state":"stated","total_value":1635.6725,"total_display":"1,635.67","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-23","filed_date":"2023-06-26","scope":"insider"},{"id":8666472,"accession":"0001437749-23-017335","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-017335","line_url":"/filing/0001437749-23-017335#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001975404","owner_name":"Watton Corey Michael","owner_url":"/insider/0001975404","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":325.0,"shares_display":"325","price_per_share":5.52,"price_display":"5.52","price_state":"stated","total_value":1794.0,"total_display":"1,794.00","shares_owned_after":725.0,"shares_owned_after_display":"725","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-06-09","filed_date":"2023-06-13","scope":"insider"},{"id":8127981,"accession":"0001437749-23-016221","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-23-016221","line_url":"/filing/0001437749-23-016221#line-1","is_derivative":false,"issuer_cik":"0001434647","issuer_name":"ZEVRA THERAPEUTICS, INC.","issuer_ticker":"ZVRA","issuer_name_source":null,"issuer_url":"/issuer/0001434647","owner_cik":"0001975404","owner_name":"Watton Corey Michael","owner_url":"/insider/0001975404","role":"Director","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":400.0,"shares_display":"400","price_per_share":5.1053,"price_display":"5.11","price_state":"stated","total_value":2042.12,"total_display":"2,042.12","shares_owned_after":400.0,"shares_owned_after_display":"400","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-05-30","filed_date":"2023-05-31","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":6,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":1,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":6},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001434647","name":"ZEVRA THERAPEUTICS, INC.","url":"/issuer/0001434647","role":"Director","n_filings":6,"first_seen":"2023-05-31","last_seen":"2026-08-12"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001975404","retrieved_at":"2026-08-21T03:03:58+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}